2021 session details

Agenda | Attendees | Hosts | Book

Open to CEO, Founder, Co-Founder, President, Chairman or c-suite executive (CFO, CBO, CCO, CSO, CMO) of US-based, pre-series A-funded, therapeutic Biotech companies.

Free to attend, pre-registration only, Chatham House Rule forum hosted on Zoom where all participants are active discussants. 

• Benchmark yourself against your peers
• Uncover key factors of success
• Share war stories and common challenges
• Engage in peer-to-peer discussion
• Make meaningful connections
• Find new ways to help your business thrive
  
  

Agenda (All times in EDT)

13:00 Welcome

Introduction from LSX to the forum, introductions from all participants and sharing of pre event benchmarking survey results

13:10 Key Insight Case Study With Q&A: How to Prevent a Bad Day for Your Start-Up: IP Lessons Learned from Company Formation, Drug Development, Partnering & Due Diligence

• How company formation and structure can affect intellectual property (IP) rights
  
• How to maintain confidentiality in early-stage deals
  
• What to disclose and to whom
  
• How to keep IP assets safe from disgruntled former employees

Chad Shear, Principal, Fish & Richardson

13:30 Executive Led Discussion: Securing Your Series A: What Investors Need to See (And What They Don't)

• What level of pre-clinical or clinical data is needed?
  
• Key milestones and the plan to reach them
  
• The value in your valuation - clear IP, development and commercial strategy

Bibhash Mukhopadhyay, Experienced Independent Investor

13:40 Interactive discussion and Q&A

13:55 Key Insight Case Study With Q&A: Partnering to Address the Challenges of a Start Up

• Understanding the challenges of a start-up with limited resources and experience
  
• Overcoming start-up hurdles
  
• Navigating the regulatory environment

Sameena Sharif, President, RPI, Premier Research
Nancy Koch, JD, CEO, Ophirex

14:15 General Discussion (suggested topics to include but not limited to)

• Securing investment from the right investors in a crowded but booming market
• Business resilience in your biotech startup from the outset
  
• Planning your clinical and regulatory roadmap  
• Building and maintaining networks early to leverage in the future
• Developing and maintaining the right partnerships to grow your business
  
  

15:00 Close Biotech Start Up CEO Forum

Join:

Co-hosts: